Lara Campana is SVP at Resolution Therapeutics, which is conducting a Phase 1/2 study named EMERALD.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lara Campana is SVP at Resolution Therapeutics, which is conducting a Phase 1/2 study named EMERALD.
Who's involved
What this event is mainly aboutLara CampanaEmerald
Keep exploring
The entities involved
-
Emerald
programming language
Nothing else this week.